L’Oréal Paris is rewriting one of its biggest success stories. The global beauty giant has quietly overhauled Revitalift Filler, the hyaluronic acid serum it calls the world’s bestselling, and relaunched it as Revitalift Hyaluronic Acid & PDRN+ Anti‑Wrinkle Plumping Serum. The upgrade comes with a fresh campaign starring Kendall Jenner in her first-ever L’Oréal Paris skin-care role.
For a product that reportedly sells a bottle every few seconds, changing the formula is a high-stakes move. L’Oréal is betting that adding a trending, clinic-inspired ingredient from South Korea to its drugstore hero can both keep loyal users on board and reignite the brand’s softer skin-care growth in key markets.
From Revitalift Filler to Revitalift PDRN+ : what actually changed
The original Revitalift Filler serum built its reputation on multi‑weight hyaluronic acid. Three forms of HA, including micro and macro molecules, are designed to work at different epidermal levels for fast plumping, deep hydration and progressive softening of fine lines. It helped establish L’Oréal Paris as the top face-care and anti-aging brand globally, across channels.
The new Revitalift Hyaluronic Acid & PDRN+ serum keeps that HA backbone and layers in PDRN, or polydeoxyribonucleotide – an “It” ingredient borrowed from South Korean aesthetic procedures and often linked with glass-skin glow. Laetitia Toupet, global brand president of L’Oréal Paris, describes the move as a “powerful renovation,” explaining that PDRN is used in in‑office treatments for fast radiance and that the brand’s biotech-derived version “can mimic the DNA of your skin.” Instead of the traditional salmon DNA origin, L’Oréal’s PDRN is produced through proprietary biotechnology.
A clinic-inspired serum built for mass beauty shelves
This launch is as much about strategy as it is about texture. In 2025, L’Oréal Paris faced headwinds in China and Europe, and while the overall brand still surpassed 7 billion euros in sales, skin care trailed the wider category’s 3.5 percent growth. “We’re beating the market in all the regions, all the categories — except skin care,” Toupet said. Her answer is to “keep on upgrading our icons with the latest technology” instead of endlessly creating new lines.
Revitalift PDRN+ is the template: a serum that echoes ingredients used in aesthetic medicine, but at a masstige price point of around 19.90 euros for 30 ml in Europe. L’Oréal leans heavily on its network of 21 research centers and AI-assisted ingredient selection to adapt formulas for different skin types and regions. The serum has started rolling out in European markets, with parts of Asia and the Middle East slated to follow between October and January 2027.
Kendall Jenner gives L’Oréal’s skin story a new face
On the campaign side, the upgrade doubles as a casting statement. Revitalift Hyaluronic Acid & PDRN+ marks the first time Kendall Jenner fronts a L’Oréal Paris skin-care launch, after years of being associated more with runway, campaigns and makeup than with anti-wrinkle formulas on the drugstore shelf. She is shot in a deliberately natural way: light makeup, minimal retouching, skin texture visible.
Toupet calls Jenner “a very empowering woman and demanding on her skin,” positioning her as proof that the formula is built for even the most exacting users. For beauty and fashion watchers, the visual direction signals where mass anti-aging is headed: less airbrushed perfection, more “real” skin backed by clinical testing imagery. The campaign assets spotlight not just the model, but also lab scenes that illustrate how the serum is formulated and tested, reinforcing the science‑driven narrative L’Oréal Paris wants around Revitalift.
What it signals for the next wave of mass anti‑aging
L’Oréal Paris has been clear about its ambition: as the self-described number-one beauty brand, it wants to use science “to transform the skin” with instant visible results and proven long‑term efficacy. Recent launches like Laser Eye Bag Eraser and the Revitalift Glass Skin range already pushed the brand closer to clinic language; PDRN+ takes that one step further by lifting a buzzy aesthetic ingredient into a global, accessible SKU.
For the wider industry, Revitalift Hyaluronic Acid & PDRN+ reads as a blueprint: established blockbuster serums refreshed with procedure-inspired actives, more realistic campaign imagery, and prices that stay firmly in mass territory. Toupet’s goal is straightforward – to make this upgraded icon a success “in every single country” and, crucially, to finally beat the market again in skin care.
